AU2001236996A1 - Compositions for topical delivery of a pharmaceutically active agent having reduced skin irritation - Google Patents
Compositions for topical delivery of a pharmaceutically active agent having reduced skin irritationInfo
- Publication number
- AU2001236996A1 AU2001236996A1 AU2001236996A AU3699601A AU2001236996A1 AU 2001236996 A1 AU2001236996 A1 AU 2001236996A1 AU 2001236996 A AU2001236996 A AU 2001236996A AU 3699601 A AU3699601 A AU 3699601A AU 2001236996 A1 AU2001236996 A1 AU 2001236996A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- active agent
- pharmaceutically active
- skin irritation
- topical delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010040880 Skin irritation Diseases 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000036556 skin irritation Effects 0.000 title 1
- 231100000475 skin irritation Toxicity 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50356800A | 2000-02-14 | 2000-02-14 | |
| US50316800A | 2000-02-14 | 2000-02-14 | |
| US09503168 | 2000-02-14 | ||
| US09503568 | 2000-02-14 | ||
| PCT/US2001/004696 WO2001060336A1 (en) | 2000-02-14 | 2001-02-13 | Compositions for topical delivery of a pharmaceutically active agent having reduced skin irritation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001236996A1 true AU2001236996A1 (en) | 2001-08-27 |
Family
ID=27054407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001236996A Abandoned AU2001236996A1 (en) | 2000-02-14 | 2001-02-13 | Compositions for topical delivery of a pharmaceutically active agent having reduced skin irritation |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU2001236996A1 (en) |
| CO (1) | CO5261579A1 (en) |
| PE (1) | PE20011092A1 (en) |
| WO (1) | WO2001060336A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020119173A1 (en) * | 2000-12-22 | 2002-08-29 | Lin Samuel Qcheng | Cosmetic compositions for preventing skin irritation |
| GB0704846D0 (en) | 2007-03-13 | 2007-04-18 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| PL214538B1 (en) * | 2009-05-28 | 2013-08-30 | P P F Hasco Lek Spolka Akcyjna | Liposome composition containing naproxen and a method for production of liposome composition containing naproxen |
| AU2014260509B2 (en) * | 2013-05-03 | 2019-08-01 | Emollivet Ab | Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4937078A (en) * | 1988-08-26 | 1990-06-26 | Mezei Associates Limited | Liposomal local anesthetic and analgesic products |
| DE4021084C1 (en) * | 1990-07-03 | 1991-11-21 | Hans Dr. 5024 Pulheim De Lautenschlaeger | Fumarate topical compsn. contg. liposome(s) improving bio-availability - esp. for treating psoriasis, contain liposomal structure, alcohol, stabiliser and fumaric acid (deriv.) and are stable and non irritant |
| US5766628A (en) * | 1992-02-24 | 1998-06-16 | Merz + Co. Gmbh & Co. | Bath and shower composition having vesicle-forming properties and method for the production and use thereof |
| DE59309714D1 (en) * | 1992-08-04 | 1999-09-09 | Rhone Poulenc Rorer Gmbh | Pharmaceutical and / or cosmetic preparation |
| US5945409A (en) * | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
-
2001
- 2001-02-12 PE PE2001000150A patent/PE20011092A1/en not_active Application Discontinuation
- 2001-02-13 CO CO01010851A patent/CO5261579A1/en not_active Application Discontinuation
- 2001-02-13 WO PCT/US2001/004696 patent/WO2001060336A1/en not_active Ceased
- 2001-02-13 AU AU2001236996A patent/AU2001236996A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001060336A1 (en) | 2001-08-23 |
| CO5261579A1 (en) | 2003-03-31 |
| PE20011092A1 (en) | 2001-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5255996A (en) | Topical formulation for local delivery of a pharmaceutically active agent | |
| AU2513900A (en) | Drug dosage unit for buccal administration of steroidal active agents | |
| AU2001263229A1 (en) | Compositions and methods for administration of pharmacologically active compounds | |
| AU2001241236A1 (en) | A therapeutic agent of osteoporosis comprising an active ingredient of quercetinderivatives | |
| AU2623600A (en) | Compact dosage unit for buccal administration of a pharmacologically active agent | |
| AU2001260414A1 (en) | Pharmaceutical compositions for transdermal administration of anti-inflammatory agents | |
| AU2001236457A1 (en) | Compounds and compositions for delivering active agents | |
| AU7706800A (en) | Delivery of small doses of ingestible treatments | |
| AU2001284985A1 (en) | Compounds and compositions for delivering active agents | |
| AU4996300A (en) | Method of electroporation-enhanced delivery of active agents | |
| AU2001289102A1 (en) | Topical formulations for delivery of interleukin-11 | |
| HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
| AU2003247616A1 (en) | Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis | |
| EP1171117A4 (en) | Long term administration of pharmacologically active agents | |
| WO2000019985A3 (en) | New sustained release oral formulations | |
| AU2003229084A1 (en) | Methods and formulations for the delivery of pharmacologically active agents | |
| EP1392241A4 (en) | System for osmotic delivery of pharmaceutically active agents | |
| HUP0400548A3 (en) | Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma | |
| AU2001288277A1 (en) | Compounds and compositions for delivering active agents | |
| AU2001295850A1 (en) | Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue | |
| AU2002229644A1 (en) | Cosmetic compositions for preventing skin irritation | |
| AU1262501A (en) | Compositions for transdermal and transmucosal administration of therapeutic agents | |
| AU2001234089A1 (en) | Cancer remedy comprising anthranilic acid derivative as active ingredient | |
| AU2002215944A1 (en) | Film for active ingredients dermal and transdermal administration | |
| CA2417935A1 (en) | Anti-inflammatory medicament |